Related references
Note: Only part of the references are listed.Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis
Simona Lattanzi et al.
ACTA NEUROLOGICA SCANDINAVICA (2019)
Palliative non-resective surgery for drug-resistant epilepsy
Simona Lattanzi et al.
BRAIN & DEVELOPMENT (2018)
Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
CEREBROVASCULAR DISEASES (2018)
Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
CNS DRUGS (2018)
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
Jerzy P. Szaflarski et al.
EPILEPSIA (2018)
Between-trial heterogeneity in meta-analyses may be partially explained by reported design characteristics
Kirsty M. Rhodes et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
Emily Stockings et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Endovascular treatment of symptomatic vertebral artery stenosis: A systematic review and meta-analysis
Simona Lattanzi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut Syndrome: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
CNS DRUGS (2018)
Eslicarbazepine acetate as adjunctive treatment in partial-onset epilepsy
S. Lattanzi et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis
Simona Lattanzi et al.
JOURNAL OF NEUROLOGY (2017)
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
Orrin Devinsky et al.
LANCET NEUROLOGY (2016)
Brivaracetam add-on for refractory focal epilepsy A systematic review and meta-analysis
Simona Lattanzi et al.
NEUROLOGY (2016)
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Alexandra L. Geffrey et al.
EPILEPSIA (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
Lacosamide monotherapy for partial onset seizures
Simona Lattanzi et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2015)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Seizure course during pregnancy in catamenial epilepsy
Claudia Cagnetti et al.
NEUROLOGY (2014)
Cannabinoids for epilepsy
David Gloss et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome
T. Glauser et al.
NEUROLOGY (2008)
How common are the common neurologic disorders?
D. Hirtz et al.
NEUROLOGY (2007)
Stiripentol in childhood partial epilepsy: Randomized placebo-controlled trial with enrichment and withdrawal design
Catherine Chiron et al.
JOURNAL OF CHILD NEUROLOGY (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)